Biogenerics Are Happening: Slowly, Product-By-Product

FDA's guidance on biogenerics is on the backburner: Congress is showing little interest in pushing the agency towards them. But some follow-on products are already making it to the market.

Ramsey Baghdadi

"When you sit in front of the managed care payers in a private one-on-one and you say: ‘What is your...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet